MedPath

Bupivacaine

Generic Name
Bupivacaine
Brand Names
Exparel, Kenalog, Marbeta, Marcaine, Marcaine With Epinephrine, Marvona Suik, P-Care M, P-Care MG, P-care, Posimir, Readysharp Anesthetics Plus Ketorolac, Readysharp-A, Readysharp-p40, Readysharp-p80, Sensorcaine, Sensorcaine With Epinephrine, Vivacaine, Xaracoll, Exparel liposomal
Drug Type
Small Molecule
Chemical Formula
C18H28N2O
CAS Number
38396-39-3
Unique Ingredient Identifier
Y8335394RO
Background

Bupivacaine is a widely used local anesthetic agent.

Indication

As an implant, bupivacaine is indicated in adults for placement into the surgical site to produce postsurgical analgesia for up to 24 hours following open inguinal hernia repair.

Bupivacaine, in liposome suspension, is indicated in patients aged 6 years and older for single-dose infiltration to produce postsurgical local analgesia. In adults, it is also indicated as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia.

Bupivacaine, in combination with meloxicam, is indicated for postsurgical analgesia in adult patients for up to 72 hours following foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures.

Bupivacaine, alone or in combination with epinephrine, is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Specific concentrations and presentations are recommended for each type of block indicated to produce local or regional anesthesia or analgesia. Finally, its use is not indicated in all blocks given clinically significant risks associated with use.

Associated Conditions
Acute Gouty Arthritis, Adrenocortical Insufficiency, Alopecia Areata (AA), Ankylosing Spondylitis (AS), Berylliosis, Bullous dermatitis herpetiformis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Dermatomyositis (DM), Discoid Lupus Erythematosus (DLE), Edema of the cerebrum, Epicondylitis, Hemolytic Anemia, Hypercalcemia caused by Cancer, Keloids Scars, Leukemias, Mycosis Fungoides (MF), Necrobiosis lipoidica diabeticorum, Ocular Inflammation, Ophthalmia, Sympathetic, Osteoarthritis (OA), Pain, Labor, Polymyositis, Postoperative pain, Psoriatic Arthritis, Psoriatic plaque, Pure Red Cell Aplasia, Regional Enteritis, Rheumatoid Arthritis, Secondary thrombocytopenia, Stevens-Johnson Syndrome, Synovitis, Systemic Lupus Erythematosus, Temporal Arteritis, Trichinosis, Tuberculous Meningitis, Ulcerative Colitis, Uveitis, Acute Bursitis, Acute Idiopathic Nephrotic Syndrome, Acute Lupus Erythematosus, Acute Multiple sclerosis, Acute Rheumatic heart disease, unspecified, Acute nonspecific tenosynovitis, Cystic tumors of aponeurosis, Cystic tumors of tendon, Disseminated Pulmonary Tuberculosis (TB), Exfoliative erythroderma, Inflammatory lesions of granuloma annulare, Inflammatory lesions of lichen planus, Inflammatory lesions of lichen simplex, Non-suppurative Thyroiditis, Permphigus, Severe Allergic Reactions
Associated Therapies
General Anesthesia, Local Anaesthesia therapy, Regional nerve block therapy

Role of Ultrasound Guide Greater Occipital Nerve Block at Second Cervical Vertebra in Migraine Headache Prophylaxis

Phase 4
Not yet recruiting
Conditions
Migraine Disorders
Interventions
Drug: Placebo
First Posted Date
2024-05-29
Last Posted Date
2024-05-29
Lead Sponsor
Mahidol University
Target Recruit Count
108
Registration Number
NCT06432127
Locations
🇹🇭

Raviwon Atisook, Bangkok, Thailand

Liposomal Bupivacaine vs Ropivacaine for TAPBs

Phase 3
Recruiting
Conditions
Ropivacaine
Postoperative Analgesia
Liposomal Bupivacaine
Abdominal Tumor
Interventions
First Posted Date
2024-05-28
Last Posted Date
2024-05-28
Lead Sponsor
Sun Yat-sen University
Target Recruit Count
74
Registration Number
NCT06430112
Locations
🇨🇳

Jingdun Xie, Guangzhou, Guangdong, China

Comparison Between (GNB) Combined With (IPACK) Block Versus ACB in TKA

Not Applicable
Completed
Conditions
Post Operative Pain
Interventions
Procedure: Adductor canal block
Procedure: Ultrasound guided Genicular nerve block
Procedure: Interspace between the popliteal artery and the capsule of the popliteal artery and the capsule of the posterior knee
First Posted Date
2024-05-21
Last Posted Date
2025-01-07
Lead Sponsor
Ain Shams University
Target Recruit Count
50
Registration Number
NCT06423339
Locations
🇪🇬

Ain shams university hospitals, Cairo, Egypt

Effect of Adding Dexamethasone to Bupivacaine 0.25% in SCPB on Surgical Field Visibility During Tympanomastoid Surgery

Phase 4
Not yet recruiting
Conditions
Surgical Field
Postoperative Pain
Interventions
First Posted Date
2024-05-16
Last Posted Date
2024-05-17
Lead Sponsor
Cairo University
Target Recruit Count
56
Registration Number
NCT06416891
Locations
🇪🇬

Faculty of Medicine, Cairo University, Cairo, Egypt

Comparison of Infraclavicular Brachial Plexus Block and Local Anesthesia in Arteriovenous Fistula Surgeries and Their Effects on Tissue Oxygen Saturation

Not Applicable
Completed
Conditions
Renal Disease, Chronic
Interventions
Device: NIRS
Other: Pinprick Test
Other: Modified Bromage Scale
First Posted Date
2024-05-16
Last Posted Date
2025-01-10
Lead Sponsor
Ankara City Hospital Bilkent
Target Recruit Count
60
Registration Number
NCT06416111
Locations
🇹🇷

Ankara Bilkent City Hospital, Ankara, Çankaya, Turkey

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

Phase 2
Recruiting
Conditions
Pancreatic Neoplasm
Duodenal Neoplasm
Interventions
Other: Medical Chart Review
Other: Questionnaire Administration
Procedure: Ultrasound Imaging
Drug: Thoracic Epidural Analgesia
Procedure: X-Ray Imaging
First Posted Date
2024-05-13
Last Posted Date
2025-05-14
Lead Sponsor
Masonic Cancer Center, University of Minnesota
Target Recruit Count
78
Registration Number
NCT06411795
Locations
🇺🇸

University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States

Comparison of the Ultrasound-guided Paravertebral Nerve Block With Liposomal Bupivacaine Versus Ropivacaine for Post-Surgical Pain After Video-Assisted Thoracoscopic Surgery

Phase 3
Not yet recruiting
Conditions
Analgesia
Interventions
First Posted Date
2024-05-08
Last Posted Date
2024-05-08
Lead Sponsor
Feng Gao
Target Recruit Count
84
Registration Number
NCT06405724
Locations
🇨🇳

Tongji Hospital, Wuhan, Hubei, China

Systemic Versus Local Dexmedetomidine As an Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Block

First Posted Date
2024-04-26
Last Posted Date
2025-02-21
Lead Sponsor
Aswan University
Target Recruit Count
75
Registration Number
NCT06386770
Locations
🇪🇬

Aswan University, Aswan, Egypt

Low Dose Bupivacaine Versus Prilocaine Regarding Hemodynamic Stability and Safety in Geriatrics

Phase 1
Completed
Conditions
Recruitment
Interventions
First Posted Date
2024-04-24
Last Posted Date
2025-03-11
Lead Sponsor
Fayoum University Hospital
Target Recruit Count
100
Registration Number
NCT06382220
Locations
🇪🇬

Fayoum University hospital, Fayoum, Faiyum Governorate, Egypt

Bupivacaine 0.125% Versus Bupivacaine 0.25% in Superficial Cervical Plexus Block for Tympanomastoid Surgeries in Adults

Phase 4
Recruiting
Conditions
Surgical Field
Acute Postoperative Pain
Interventions
First Posted Date
2024-04-24
Last Posted Date
2024-05-07
Lead Sponsor
Cairo University
Target Recruit Count
60
Registration Number
NCT06381401
Locations
🇪🇬

Faculty of Medicine, Cairo University, Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath